Aladar Szalay - Net Worth and Insider Trading

Aladar Szalay Net Worth

The estimated net worth of Aladar Szalay is at least $1 Million dollars as of 2024-06-06. Aladar Szalay is the 10% Owner of Genelux Corp and owns about 555,000 shares of Genelux Corp (GNLX) stock worth over $1 Million. Details can be seen in Aladar Szalay's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Aladar Szalay has not made any transactions after 2024-05-15 and currently still holds the listed stock(s).

Transaction Summary of Aladar Szalay

To

Aladar Szalay Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aladar Szalay owns 1 companies in total, including Genelux Corp (GNLX) .

Click here to see the complete history of Aladar Szalay’s form 4 insider trades.

Insider Ownership Summary of Aladar Szalay

Ticker Comapny Transaction Date Type of Owner
GNLX Genelux Corp 2024-05-15 10 percent owner

Aladar Szalay Latest Holdings Summary

Aladar Szalay currently owns a total of 1 stock. Aladar Szalay owns 555,000 shares of Genelux Corp (GNLX) as of May 15, 2024, with a value of $1 Million.

Latest Holdings of Aladar Szalay

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GNLX Genelux Corp 2024-05-15 555,000 2.54 1,409,700

Holding Weightings of Aladar Szalay


Aladar Szalay Form 4 Trading Tracker

According to the SEC Form 4 filings, Aladar Szalay has made a total of 16 transactions in Genelux Corp (GNLX) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Genelux Corp is the sale of 35,966 shares on May 15, 2024, which brought Aladar Szalay around $130,197.

Insider Trading History of Aladar Szalay

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aladar Szalay Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Aladar Szalay Ownership Network

Ownership Network List of Aladar Szalay

No Data

Ownership Network Relation of Aladar Szalay

Insider Network Chart

Aladar Szalay Owned Company Details

What does Genelux Corp do?

Who are the key executives at Genelux Corp?

Aladar Szalay is the 10 percent owner of Genelux Corp. Other key executives at Genelux Corp include VP & Clinical Trial Operations Tony Yu , General Counsel Sean Ryder , and Chief Financial Officer Lourie S. Zak .

Genelux Corp (GNLX) Insider Trades Summary

Over the past 18 months, Aladar Szalay made 16 insider transaction in Genelux Corp (GNLX) with a net sale of 646,416. Other recent insider transactions involving Genelux Corp (GNLX) include a net sale of 191,000 shares made by Tony Yu , a net sale of 19,000 shares made by John Thomas , and a net sale of 10,328 shares made by Sean Ryder .

In summary, during the past 3 months, insiders sold 231,724 shares of Genelux Corp (GNLX) in total and bought 0 shares, with a net sale of 231,724 shares. During the past 18 months, 891,005 shares of Genelux Corp (GNLX) were sold and 200 shares were bought by its insiders, resulting in a net sale of 890,805 shares.

Genelux Corp (GNLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Genelux Corp Insider Transactions

No Available Data

Aladar Szalay Mailing Address

Above is the net worth, insider trading, and ownership report for Aladar Szalay. You might contact Aladar Szalay via mailing address: C/o Genelux Corporation, 2625 Townsgate Road, Suite 230, Westlake Village Ca 91361.

Discussions on Aladar Szalay

No discussions yet.